Isaac Manke - 01 Apr 2024 Form 4 Insider Report for Q32 Bio Inc. (QTTB)

Role
Director
Signature
/s/ Eric Bell, Attorney-in-Fact
Issuer symbol
QTTB
Transactions as of
01 Apr 2024
Net transactions value
+$35,254
Form type
4
Filing time
30 Sep 2024, 06:01:05 UTC
Previous filing
27 Mar 2024
Next filing
08 Oct 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QTTB Stock Option (Right to Buy) Award $35,254 +2,627 $13.42 2,627 01 Apr 2024 Common Stock 2,627 $18.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive equity in lieu of cash compensation for services as a non-employee director of the Issuer.
F2 The shares underlying this option vest in three equal quarterly installments on each of June 30, 2024, September 30, 2024 and December 31, 2024.